| Trial ID: | L6418 |
| Source ID: | NCT00300911
|
| Associated Drug: |
Rosiglitazone(Drug), Cardiac Adverse Effects
|
| Title: |
Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Rosiglitazone(drug), cardiac adverse effects
|
| Outcome Measures: |
Primary: Plasma Brain Natriuretic Peptide levels, echocardiographic measurements were made before the treatment and repeated after three months and six months of the treatment |
|
| Sponsor/Collaborators: |
Sponsor: Baskent University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
45
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-12
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2006-03-10
|
| Locations: |
Baskent University Ankara Hospital, Ankara, 06490, Turkey
|
| URL: |
https://clinicaltrials.gov/show/NCT00300911
|
